Pharmafile Logo
Pharmafocus logo
Advanced Search

Ranbaxy

Showing 15 posts of 45 posts found.

sun_pharma

Under fire Ranbaxy sold to Sun Pharma for $4 billion

April 7, 2014
Manufacturing and Production, Sales and Marketing FDA, Ranbaxy, Sun Pharma, deal, hamburg, manufacturing

Sun Pharmaceutical Industries has bought struggling drugmaker Ranbaxy Laboratories in a deal that will see the two companies become the …

News
Ranbaxy image

Ranbaxy hit with second generic Lipitor recall

March 10, 2014
Manufacturing and Production, Sales and Marketing Daiichi Sankyo, FDA, Ranbaxy, hamburg, manufacturing

India’s largest native generic drugmaker Ranbaxy has come under greater pressure this week after the US has again sent out …

News
ranbaxy image

FDA extends Ranbaxy ban

January 27, 2014
Manufacturing and Production, Sales and Marketing API, FDA, Ranbaxy, toansa

India-based generic manufacturer Ranbaxy Laboratories has been dealt a further blow as the US regulator has banned more of its …

News
Ranbaxy image

Ranbaxy quality issues hit sixth plant; seeks Diovan workaround

January 20, 2014
Manufacturing and Production FDA, Ranbaxy, fines, manufacturing

Yet another plant operated by India’s Ranbaxy has been held up by US Food and Drug Administration over quality deficiencies, …

News
Ranbaxy image

FDA throws Ranbaxy a manufacturing lifeline

October 15, 2013
Manufacturing and Production FDA, Ranbaxy, recall

Problems have plagued Ranbaxy’s manufacturing operations in the last couple of years, but it enjoyed a bit of light relief …

News

Ranbaxy hit as third plant comes under FDA import alert

September 17, 2013
Manufacturing and Production Ranbaxy

News
Ranbaxy image

Ranbaxy taps into Malaysian growth with second facility

August 9, 2013
Manufacturing and Production ASEAN, Ranbaxy, asian, malaysian

Indian drugmaker Ranbaxy has signed a deal to construct a new $35 million manufacturing facility in Malaysia that will triple …

News
Ranbaxy image

Ranbaxy facing another facility problem?

June 26, 2013
Manufacturing and Production FDA, Ranbaxy

Another facility operated by Ranbaxy Laboratories in India is reported to have failed an inspection by the FDA, potentially adding …

News

Nine fined in EU pay-for-delay deals

June 20, 2013
Manufacturing and Production, Sales and Marketing EU, Lundbeck, Merck, Ranbaxy

Nine pharma firms have been handed hefty fines by the European Commission over allegations that they willingly blocked generic versions …

News
Ranbaxy image

Ranbaxy unit fined $500m for selling adulterated drugs

May 14, 2013
Manufacturing and Production FDA, GMP, Ranbaxy, fine, generics

Ranbaxy’s US subsidiary has agreed to pay fines and penalties totalling $500 million after pleading guilty to charges of manufacturing …

News
Ranbaxy image

Ranbaxy suspends atorvastatin manufacturing after recall

November 30, 2012
Manufacturing and Production FDA, Ranbaxy, atorvastatin, recall

Ranbaxy Laboratories has called a halt to manufacturing its generic atorvastatin product until it can get to the bottom of …

News

Glass particles force recall of Ranbaxy Lipitor

November 27, 2012
Manufacturing and Production, Sales and Marketing Daiichi Sankyo, Lipitor, Pfizer, Ranbaxy, recall

Ranbaxy Pharmaceuticals is recalling around 40 batches of its generic atorvastatin tablets after discovering that some of the product may …

News

Pharma manufacturing news in brief

September 17, 2012
Manufacturing and Production Ampio, DPT Labs, Ethypharm, ICH, PC Pharma, Ranbaxy

Ranbaxy and PC Pharma unveil new facility investments, Ethypharm will manufacture Ampio drug, DPT Labs is warned by the FDA …

News
Takeda's Actos

Generic Actos gains FDA approval

August 20, 2012
Sales and Marketing Actos, Mylan, Ranbaxy, Takeda, diabetes, generic

Takeda’s big-selling diabetes pill Actos will have its US sales decimated after the FDA approves three copycat versions of the …

News

Ranbaxy launches generic Lipitor in Europe

March 6, 2012
Research and Development, Sales and Marketing Lipitor, Pfizer, Ranbaxy, atorvastatin, generics

Ranbaxy has launched its generic version of Pfizer’s Lipitor in Europe, months ahead of its May expiration date.  The Indian …

News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026